Dermata Therapeutics (DRMAW) Short Interest Ratio & Short Volume → Biden replacement revealed? (From Paradigm Press) (Ad) Free DRMAW Stock Alerts $0.02 +0.01 (+144.93%) (As of 05/1/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestSocial Media Dermata Therapeutics Short Interest DataCurrent Short Volume11,000 sharesPrevious Short Volume9,500 sharesChange Vs. Previous Month+15.79%Dollar Volume Sold Short$101.20Short Interest Ratio / Days to Cover2.2Last Record DateApril 15, 2024Today's Trading Volume252 sharesAverage Trading Volume9,844 sharesToday's Volume Vs. Average3% Short Selling Dermata Therapeutics ? Sign up to receive the latest short interest report for Dermata Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDRMAW Short Interest Over TimeDRMAW Days to Cover Over TimeDRMAW Percentage of Float Shorted Over Time Ad InvestorPlaceHave You Seen Elon’s New A.I. Device? (Picture Inside)A strange new era for mankind is upon us... And it's all thanks to Elon Musk's latest creation. Click here to see this strange device you could be wearing some day. Elon believes A.I. is advancing so fast...This strange new device to protect us against that A.I. threat... Dermata Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202411,000 shares $101.20 +15.8%N/A2.2 $0.01 3/31/20249,500 shares $90.25 -24.6%N/A1.6 $0.01 3/15/202412,600 shares $141.12 +20.0%N/A2.2 $0.01 2/29/202410,500 shares $165.90 -8.7%N/A1.8 $0.02 2/15/202411,500 shares $143.75 +17.4%N/A2.3 $0.01 1/31/20249,800 shares $245.00 -26.3%N/A2 $0.03 Get the Latest News and Ratings for DRMAW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Dermata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/202413,300 shares $275.31 +4.7%N/A3.2 $0.02 12/31/202312,700 shares $88.90 -0.8%N/A3.3 $0.01 12/15/202312,800 shares $281.60 No ChangeN/A4.6 $0.02 11/30/202312,800 shares $268.80 No ChangeN/A5.8 $0.02 11/15/202312,800 shares $157.44 No ChangeN/A3.9 $0.01 10/31/202312,800 shares $153.60 -2.3%N/A4 $0.01 10/15/202313,100 shares $327.50 No ChangeN/A3.9 $0.03 9/30/202313,100 shares $229.25 +1.6%N/A3.4 $0.02 9/15/202312,900 shares $313.47 -18.4%N/A2.3 $0.02 8/31/202315,800 shares $284.40 +16.2%N/A2.8 $0.02 8/15/202313,600 shares $390.32 -19.5%N/A2.3 $0.03 7/31/202316,900 shares $338.00 -18.0%N/A1.7 $0.02 7/15/202320,600 shares $587.10 +57.3%N/A1.6 $0.03 6/30/202313,100 shares $327.50 -5.8%N/A0.6 $0.03 6/15/202313,900 shares $223.79 +2.2%N/A0.6 $0.02 5/31/202313,600 shares $448.80 -26.1%N/A0.6 $0.03 5/15/202318,400 shares $276.00 No ChangeN/A0.8 $0.02 8/15/2022300 shares $44.04 -57.1%N/A0 $0.15 7/31/2022700 shares $58.80 -61.1%N/A0.1 $0.08 7/15/20221,800 shares $155.34 No ChangeN/A0.2 $0.09 4/30/2022500 shares $73.50 +25.0%N/A0 $0.15 4/15/2022400 shares $63.96 -55.6%N/A0 $0.16 3/31/2022900 shares $0.00 No ChangeN/A0.1 $0.00 DRMAW Short Interest - Frequently Asked Questions What is Dermata Therapeutics' current short interest? Short interest is the volume of Dermata Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 11,000 shares of DRMAW short. Learn More on Dermata Therapeutics' current short interest. What is a good short interest ratio for Dermata Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DRMAW shares currently have a short interest ratio of 2.0. Learn More on Dermata Therapeutics's short interest ratio. Is Dermata Therapeutics' short interest increasing or decreasing? Dermata Therapeutics saw a increase in short interest in April. As of April 15th, there was short interest totaling 11,000 shares, an increase of 15.8% from the previous total of 9,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Dermata Therapeutics stock? Short selling DRMAW is an investing strategy that aims to generate trading profit from Dermata Therapeutics as its price is falling. DRMAW shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Dermata Therapeutics? A short squeeze for Dermata Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of DRMAW, which in turn drives the price of the stock up even further. How often is Dermata Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRMAW, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: ATNFW Short Interest DRTSW Short Interest APLMW Short Interest ARTLW Short Interest BCTXW Short Interest CDIOW Short Interest CTCXW Short Interest SAVAW Short Interest CELUW Short Interest CLNNW Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DRMAW) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceDollar CancelledLear CapitalRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press